CVS to sell CBD-infused topical products in 800 stores across 8 states
Category: #retail  By Pankaj Singh  Date: 2019-03-23
  • share
  • Twitter
  • Facebook
  • LinkedIn

CVS to sell CBD-infused topical products in 800 stores across 8 states

CVS has partnered with cannabis producers to infuse CBD and sell topical products like roll-ons, lotions, creams, slaves and sprays.

CVS pharmacy has announced that it would sell hemp-derived CBD products, or products with cannabidiol, which is non-psychoactive component of marijuana, in about 800 stores in states including Colorado, Illinois, Indiana, California, Maryland, Indiana, Kentucky and Tennessee. CVS has partnered with cannabis producers to infuse CBD and sell topical products like roll-ons, lotions, creams, slaves and sprays.

As per reported by WFLA TV, CVS stated that it is not selling CBD containing food additives or supplements as it is illegal to add drugs like CBD in food supply. CBD is derived from cannabis plant and is non-psychoactive. So far, there is no approval of Food and Drug Administration to use CBD in food or beverage products.

CVS Health CEO, Larry Merlo reportedly quoted stating that they have feedbacks from their customers that these products are relieving them from pain for arthritis and other ailments. He further added that they will keep their pace slow, but they think that customer will demand more for these products as a part of health offerings.

Cannabis species hemp has no psychoactive compounds that can cause user to get high, like marijuana. Hemp is not a controlled substance now so there are more business opportunities in creating hemp-based products like tinctures and lotions. There are a lot many ways to use CBD but studies on CBD are limited yet.

Reportedly, CVS stated that they are not claiming a ‘cure-all’ product as effectiveness may vary from product to product.

According to experts, CBD has been used for treatment of inflammation, pain, anxiety and cancer. Epidiolex is the only FDA approved CBD oil which is prescribed to treat seizures related with two rare, severe forms of epilepsy.

CVS has collaborated with Eurofins, which is a third-party laboratory, to ensure labeling and safety of customers. They will test all CBD topicals for CBD, THC content and other contaminants.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Flipkart launches Loyalty Program across 5,000 retail outlets in India
Flipkart launches Loyalty Program across 5,000 retail outlets in India
By Pankaj Singh

E-commerce giant Flipkart has recently launched SuperCoin Pay, a system of currency which its customers will have the right to use across tons of retail stores in the country. Flipkart is betting on its loyalty program...

Sirnaomics reveals dose administration of 1st patient in STP705 trial
Sirnaomics reveals dose administration of 1st patient in STP705 trial
By Pankaj Singh

Sirnaomics, Inc., a clinical-stage biopharmaceutical company, has recently announced the dose administration of the 1st patient in a Phase 2a clinical trial of STP705. STP705 is a lead drug candidate develop...

Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
By Pankaj Singh

The pharma giant Pfizer Inc. has reportedly declared that the U.S. Food and Drug Administration (US FDA) has approved the sNDA (supplemental New Drug Application) for XALKORI® (crizotinib) for the treatment of chil...